scispace - formally typeset
T

Takeshi Kinjo

Researcher at University of the Ryukyus

Publications -  96
Citations -  3283

Takeshi Kinjo is an academic researcher from University of the Ryukyus. The author has contributed to research in topics: Medicine & Pneumonia. The author has an hindex of 18, co-authored 82 publications receiving 2763 citations. Previous affiliations of Takeshi Kinjo include National Cancer Research Institute.

Papers
More filters
Journal ArticleDOI

CpG DNA as a vaccine adjuvant

TL;DR: Clinical trials demonstrate that CpG ODNs have a good safety profile and increase the immunogenicity of coadministered vaccines.
Journal ArticleDOI

Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans.

TL;DR: Protective immunity to pneumocystis, but not to candida, required dectin-1 for the production of antifungal reactive oxygen species, and wild-type and dectIn-1-knockout mice were equally susceptible to candidA infection.
Journal ArticleDOI

TLR-based immune adjuvants.

TL;DR: The nature and strength of the immune response induced by various Toll-like receptor ligands and their ability to act as vaccine adjuvants are described and those agents for which clinical results are available are reviewed.
Journal ArticleDOI

Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection

TL;DR: MCP‐1‐dependent recruitment of Vα14+ NKT cells and their critical role in early host protection against S. pneumoniae by promoting the trafficking of neutrophils to the site of infection are demonstrated.
Journal ArticleDOI

Dectin-1 is not required for the host defense to Cryptococcus neoformans.

TL;DR: Results indicate that dectin‐1 is not likely essential for the development of host protective responses to C. neoformans, an opportunistic fungal pathogen in AIDS patients.